Serge Kechichian Joins Forces for a Charitable Swing at the DCAT Scholarship Golf Outing
Our very own Serge Kechichian is all set to tee it up for a cause with colleagues, suppliers, and customers in support of the DCAT (Drug, …
We’re honored to have Alexandra Pichard Nielsen, Vice President for Business Development at Porton Pharma Solutions Ltd., join us at BOS Basel 2023!
We are excited to witness Alexandra’s expertise and leadership in action as she explores new opportunities, fosters …
Dr. Angelo Maria Manzo, our esteemed Senior Business Development Manager at Porton Pharma Solutions Ltd., joins us at BOS Basel 2023!
Angelo’s deep industry knowledge and strategic vision are set to make a remarkable impact as he explores new collaborations, …
We are thrilled to announce the establishment of our state-of-the-art Small Molecule Platform in Shanghai, revolutionizing our CDMO services. With this exciting development, Porton Pharma Solutions Ltd. now have seven R&D and production facilities in Shanghai that are equipped to …
Join us in welcoming Dr. Wenfang Miao (Renee) as the new CEO of Porton Pharma Solutions Ltd. USA and J-STAR Research, Inc., and Vice-President of Porton Pharma Solutions, LTD. Dr. Miao brings with her more than 25 years of experience …
Our very own Serge Kechichian is all set to tee it up for a cause with colleagues, suppliers, and customers in support of the DCAT (Drug, Chemical & Associated Technologies Association) Scholarship Golf Outing. Under DCAT’s Science and Scholarship Committee’s …
Join J-STAR Research, Inc. Executive Director of Computational Chemistry and Data Science, Yuriy Abramov, Ph.D., as he takes the stage as an invited speaker at the 6th David Grand Symposium on June 15. He will share his insights on computational …
On May 8, 2023, Porton Pharma Solutions Ltd. (stock code: 300363) celebrated the grand opening of its Small Molecule Business Platform Headquarters, located in Minhang Economic and Technological Development Zone, Shanghai. This momentous event attracted nearly 200 representatives ranging from …
On April 11, 2023, Shanghai Porton Nova Biologics, Ltd., a wholly-owned subsidiary of Porton Pharma Solutions Ltd., officially launched the construction of its biologics R&D and manufacturing site in the Waigaoqiao Free Trade Zone of Pudong New Area, Shanghai, China. …
J-STAR Research is a proud sponsor of this year’s Empowering Women in Organic Chemistry Conference (EWOC). The EWOC has a mission of empowerment along with promoting networking, community, and amazing science! The EWOC is dedicated to equity, justice, diversity, …
NEW YORK, NY – On March 20th through March 23rd, 2023, Midtown New York City was home to the 95th Annual DCAT Week, one of the world’s largest and highly recognized and attended business events …
Porton Pharma Solutions Ltd. recently released 2022 CSR Report which is its seventh CSR report since IPO. This report demonstrates the company’s ideas and achievements in fulfilling social responsibility from aspects such as “improving corporate governance”, “providing high-quality services”, “empowering …
